
About Makers Laboratories Ltd
Data last updated:
Makers Laboratories Ltd is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 July 1984 and has been in existence for over 42 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L24230MH1984PLC033389. Its GSTIN is 27AAACM8382J2Z1 (Maharashtra). The company holds 14 GST registrations, of which 4 are active. Its shares are listed on BSE: 506919.
The company has an authorised share capital of ₹7.5 Cr and a paid-up capital of ₹5.9 Cr. It is led by directors including Saahil Umesh Parikh (Whole-Time Director) and Nilesh Jain (Whole-Time Director).
Its last annual general meeting (AGM) was held on 08 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 54D Kandivli Industrial Estate Kandivli(West), Mumbai, Maharashtra, India – 400067.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹140.59 Cr, a growth of 16.4% compared to the previous year. For the same year it recorded a net profit of ₹2.09 Cr (net margin 1.5%) and EBITDA of ₹14.82 Cr (EBITDA margin 10.5%). The net worth stands at ₹72.92 Cr (up 3.4% YoY). Total assets are valued at ₹131.63 Cr (up 6.8% YoY).
The company has about 139 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Makers Laboratories. As per MCA filings, the company has open charges of ₹21.32 Cr and satisfied charges of ₹30.67 Cr on record. Court records list 51 cases involving the company, including 41 filed by the company and 5 filed against it; 18 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website makerslabs.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No. 54D Kandivli Industrial Estate Kandivli(West), Mumbai, Maharashtra, India – 400067
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
CIN History of Makers Laboratories Ltd
Makers Laboratories has one previous CIN (Corporate Identification Number): U24230MH2004PTC033389. The current CIN is L24230MH1984PLC033389, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24230MH1984PLC033389 | Current |
| U24230MH2004PTC033389 | Previous |
Associated Brands with Makers Laboratories Ltd
Makers Laboratories operates one associated brand: Makers Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Branded generic pharmaceutical products are manufactured across multiple therapeutic segments. | makerslabs.com |
Business Activity of Makers Laboratories Ltd
The main business activity of Makers Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Makers Laboratories Ltd
Makers Laboratories Ltd is audited by Natvarlal Vepari & Co. for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Natvarlal Vepari & Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Makers Laboratories Ltd
Makers Laboratories has 6 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raj Kamal Prasad Verma Also directs: Resonance Specialties Limited, Evse Ready India Private Limited, Numantra Technologies Private Limited and 2 more | Director | 13 Feb 2019 | 7 Years 7 Months | Current |
| Prashant Godha | Director | 04 Nov 2020 | 5 Years 11 Months | Current |
| Vishal Babulal Jain Also directs: V Everywhere Foods LLP, Vipra Closures Private Limited | Director | 04 Nov 2020 | 5 Years 11 Months | Current |
| Saahil Umesh Parikh | Whole-Time Director | 02 Aug 2012 | 14 Years 2 Months | Current |
| Dipti Chinubhai Shah Also directs: Krebs Biochemicals and Industries Limited | Director | 29 Jan 2018 | 8 Years 8 Months | Current |
| Nilesh Jain Also directs: Resonance Specialties Limited | Whole-Time Director | 13 Feb 2019 | 7 Years 7 Months | Current |
Financials of Makers Laboratories Ltd FY 2025-26 filings available
Makers Laboratories Ltd reported revenue of ₹140.59 Cr (up 16.4% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | 141 | 121 | 104 | 101 | 127 | 68.64 |
| Revenue growth | +16.4% | +15.7% | +3.1% | -20.4% | +85.3% | - |
| EBITDA | 14.82 | 7.60 | 1.12 | 3.33 | 18.82 | 8.12 |
| EBITDA margin | +10.5% | +6.3% | +1.1% | +3.3% | +14.8% | +11.8% |
| Profit before tax | 11.15 | 13.41 | (3.91) | (0.83) | 15.70 | 2.71 |
| Net profit | 2.09 | (3.67) | (6.29) | (4.76) | 4.97 | (0.42) |
| Net profit margin | +1.5% | -3.0% | -6.0% | -4.7% | +3.9% | -0.6% |
| EPS (₹) | 3.98 | 12.70 | (10.62) | (8.05) | 10.12 | (0.67) |
| Balance sheet | ||||||
| Total assets | 132 | 123 | 128 | 128 | 122 | 107 |
| Net worth | 72.92 | 70.51 | 63.05 | 69.20 | 59.58 | 54.13 |
| Total debt | 8.74 | 7.78 | 22.13 | 16.71 | 23.00 | 20.51 |
| Cash & bank | 0.63 | 0.65 | 2.23 | 4.37 | 8.67 | 6.22 |
| Net working capital | 48.05 | 51.44 | 41.26 | 46.31 | 48.27 | 39.95 |
| Cash flow | ||||||
| Cash from operations | 14.29 | (4.08) | 0.84 | (8.62) | 18.50 | 0.00 |
| Cash from investing | (14.69) | 19.75 | (6.89) | 1.25 | (21.79) | 0.00 |
| Cash from financing | 0.35 | (15.84) | 5.74 | 5.78 | 0.33 | 0.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 42.77 | 35.75 | 35.67 | 34.17 | 35.00 | 33.90 | 27.69 | 29.57 |
| Revenue growth (YoY) | +22.2% | +5.5% | +28.8% | +15.6% | +18.3% | - | - | - |
| Other income | 0.61 | 0.76 | 0.33 | 0.36 | 0.27 | 0.12 | 0.87 | 10.63 |
| EBITDA | 6.96 | 5.27 | 4.17 | 2.28 | 3.01 | 3.06 | 1.31 | 2.19 |
| EBITDA margin | +16.3% | +14.7% | +11.7% | +6.7% | +8.6% | +9.0% | +4.7% | +7.4% |
| Depreciation | 1.13 | 1.13 | 1.14 | 1.13 | 1.12 | 0.90 | 1.31 | 1.29 |
| Interest | 0.15 | 0.17 | 0.20 | 0.22 | 0.18 | 0.18 | 0.19 | 0.43 |
| Profit before tax | 6.29 | 4.73 | 3.16 | 1.29 | 1.98 | 2.10 | 0.68 | 11.10 |
| Tax | 1.70 | 1.18 | 0.88 | 0.55 | 0.69 | 0.52 | 0.41 | 1.33 |
| Net profit | 4.59 | 3.55 | 2.28 | 0.74 | 1.29 | 1.58 | 0.27 | 9.77 |
| EPS (₹) | 2.55 | 1.85 | 1.59 | (0.20) | 0.74 | (0.08) | (0.50) | 14.94 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 50.35 | 42.94 | 49.09 | 42.55 | 52.38 | 44.41 | 51.31 |
| Revenue growth | +17.3% | -12.5% | +15.4% | -18.8% | +18.0% | -13.5% | - |
| EBITDA | 0.73 | (2.21) | (3.76) | (4.12) | 3.07 | 3.31 | 2.73 |
| EBITDA margin | +1.5% | -5.2% | -7.7% | -9.7% | +5.9% | +7.5% | +5.3% |
| Profit before tax | (2.01) | 4.92 | (6.95) | (6.76) | 0.33 | (2.08) | 0.27 |
| Net profit | (1.73) | (5.76) | (6.97) | (6.36) | 0.23 | (1.79) | (0.10) |
| Net profit margin | -3.4% | -13.4% | -14.2% | -15.0% | +0.4% | -4.0% | -0.2% |
| EPS (₹) | (2.91) | 7.87 | (11.78) | (10.78) | 0.35 | (3.29) | (0.25) |
| Balance sheet | |||||||
| Total assets | 58.58 | 58.00 | 67.99 | 70.69 | 69.90 | 65.83 | 57.85 |
| Net worth | 54.43 | 56.08 | 51.45 | 58.28 | 50.30 | 49.62 | 44.62 |
| Total debt | 3.88 | 1.76 | 15.37 | 11.20 | 19.40 | 15.99 | 13.05 |
| Cash & bank | 0.03 | 0.04 | 0.07 | 0.08 | 0.14 | 0.34 | 0.96 |
| Net working capital | 5.29 | 3.16 | 2.89 | 5.26 | 6.40 | 10.39 | 9.42 |
| Cash flow | |||||||
| Cash from operations | (2.02) | (1.59) | (3.06) | (1.42) | 6.80 | 0.67 | 4.23 |
| Cash from investing | 0.28 | 16.14 | (2.04) | (3.55) | (8.78) | (2.65) | (8.43) |
| Cash from financing | 1.75 | (14.56) | 5.12 | 4.94 | 1.77 | 1.37 | 2.91 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 10.19 | 11.27 | 12.70 | 12.64 | 13.73 | 9.70 | 9.45 | 11.50 |
| Revenue growth (YoY) | -25.8% | +16.2% | +34.4% | +9.9% | +11.7% | - | - | - |
| Other income | 0.07 | 0.02 | 0.00 | 0.53 | 0.04 | 0.03 | 0.57 | 10.19 |
| Total expenses | 10.69 | 11.65 | 11.99 | 12.72 | 13.26 | 10.91 | 10.01 | 11.67 |
| EBITDA | (0.50) | (0.38) | 0.71 | (0.08) | 0.47 | (1.21) | (0.56) | (0.17) |
| EBITDA margin | -4.9% | -3.4% | +5.6% | -0.6% | +3.4% | -12.5% | -5.9% | -1.5% |
| Depreciation | 0.69 | 0.69 | 0.71 | 0.71 | 0.70 | 0.69 | 0.73 | 0.71 |
| Interest | 0.14 | 0.12 | 0.15 | 0.15 | 0.10 | 0.09 | 0.13 | 0.33 |
| Profit before tax | (1.26) | (1.17) | (0.15) | (0.41) | (0.29) | (1.96) | (0.85) | 8.98 |
| Tax | (0.18) | (0.20) | 0.03 | (0.10) | (0.03) | (0.57) | (0.08) | 0.95 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 42.77 | 35.75 | 35.67 | 34.17 | 35.00 | 33.90 | 27.69 | 29.57 |
| Revenue growth (YoY) | +22.2% | +5.5% | +28.8% | +15.6% | +18.3% | - | - | - |
| Other income | 0.61 | 0.76 | 0.33 | 0.36 | 0.27 | 0.12 | 0.87 | 10.63 |
| EBITDA | 6.96 | 5.27 | 4.17 | 2.28 | 3.01 | 3.06 | 1.31 | 2.19 |
| EBITDA margin | +16.3% | +14.7% | +11.7% | +6.7% | +8.6% | +9.0% | +4.7% | +7.4% |
| Depreciation | 1.13 | 1.13 | 1.14 | 1.13 | 1.12 | 0.90 | 1.31 | 1.29 |
| Interest | 0.15 | 0.17 | 0.20 | 0.22 | 0.18 | 0.18 | 0.19 | 0.43 |
| Profit before tax | 6.29 | 4.73 | 3.16 | 1.29 | 1.98 | 2.10 | 0.68 | 11.10 |
| Tax | 1.70 | 1.18 | 0.88 | 0.55 | 0.69 | 0.52 | 0.41 | 1.33 |
| Net profit | 4.59 | 3.55 | 2.28 | 0.74 | 1.29 | 1.58 | 0.27 | 9.77 |
| EPS (₹) | 2.55 | 1.85 | 1.59 | (0.20) | 0.74 | (0.08) | (0.50) | 14.94 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Revenue | 141 | 121 | 104 | 101 | 127 | 68.64 |
| Revenue growth | +16.4% | +15.7% | +3.1% | -20.4% | +85.3% | - |
| Other income | 1.71 | 11.89 | 1.53 | 2.28 | 2.64 | 0.96 |
| Total expenses | 126 | 113 | 103 | 97.95 | 108 | 60.52 |
| Employee cost | 15.59 | 14.05 | 13.94 | 11.73 | 12.51 | 8.71 |
| EBITDA | 14.82 | 7.60 | 1.12 | 3.33 | 18.82 | 8.12 |
| EBITDA margin | +10.5% | +6.3% | +1.1% | +3.3% | +14.8% | +11.8% |
| Depreciation | 4.53 | 4.79 | 4.54 | 4.24 | 4.02 | 4.61 |
| Interest | 0.85 | 1.29 | 2.02 | 2.20 | 1.74 | 1.76 |
| Profit before tax | 11.15 | 13.41 | (3.91) | (0.83) | 15.70 | 2.71 |
| Tax | 3.29 | 2.51 | 0.89 | 1.35 | 3.97 | 1.36 |
| Net profit | 2.09 | (3.67) | (6.29) | (4.76) | 4.97 | (0.42) |
| Net profit margin | +1.5% | -3.0% | -6.0% | -4.7% | +3.9% | -0.6% |
| EPS (₹) | 3.98 | 12.70 | (10.62) | (8.05) | 10.12 | (0.67) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Equity & liabilities | ||||||
| Share capital | 5.90 | 5.90 | 5.90 | 5.90 | 4.92 | 4.92 |
| Reserves & surplus | 67.02 | 64.61 | 57.15 | 63.30 | 54.66 | 49.21 |
| Shareholders' funds (net worth) | 72.92 | 70.51 | 63.05 | 69.20 | 59.58 | 54.13 |
| Minority interest | 49.55 | 44.69 | 41.29 | 40.47 | 38.51 | 32.44 |
| Secured loans | 1.03 | 2.06 | 9.08 | 6.91 | 5.53 | 7.98 |
| Unsecured loans | 7.71 | 5.72 | 13.05 | 9.80 | 17.47 | 12.53 |
| Total debt | 8.74 | 7.78 | 22.13 | 16.71 | 23.00 | 20.51 |
| Total liabilities | 132 | 123 | 128 | 128 | 122 | 107 |
| Assets | ||||||
| Gross block | 120 | 119 | 136 | 130 | 110 | 81.94 |
| Net block | 70.54 | 74.16 | 86.56 | 84.53 | 68.30 | 71.39 |
| Capital work in progress | 3.73 | 0.59 | 0.32 | 0.49 | 9.38 | 0.16 |
| Investments | 11.73 | 0.14 | 2.93 | 0.08 | 0.22 | 1.97 |
| Inventories | 44.94 | 34.04 | 33.80 | 31.32 | 23.84 | 27.47 |
| Sundry debtors | 19.86 | 28.04 | 19.89 | 19.87 | 13.55 | 16.61 |
| Cash & bank balances | 0.63 | 0.65 | 2.23 | 4.37 | 8.67 | 6.22 |
| Loans & advances | 9.95 | 5.55 | 11.06 | 7.70 | 16.84 | 10.00 |
| Total current assets | 75.38 | 68.28 | 66.98 | 63.26 | 62.90 | 60.30 |
| Total current liabilities | 27.33 | 16.84 | 25.72 | 16.95 | 14.63 | 20.35 |
| Net working capital | 48.05 | 51.44 | 41.26 | 46.31 | 48.27 | 39.95 |
| Total assets | 132 | 123 | 128 | 128 | 122 | 107 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Opening cash | 0.24 | 0.41 | 0.72 | 2.31 | 5.27 | 0.00 |
| Net cash from operating activities | 14.29 | (4.08) | 0.84 | (8.62) | 18.50 | 0.00 |
| Net cash from investing activities | (14.69) | 19.75 | (6.89) | 1.25 | (21.79) | 0.00 |
| Net cash from financing activities | 0.35 | (15.84) | 5.74 | 5.78 | 0.33 | 0.00 |
| Net change in cash | (0.05) | (0.17) | (0.31) | (1.59) | (2.96) | 0.00 |
| Closing cash | 0.63 | 0.65 | 2.23 | 4.37 | 8.67 | 6.22 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Growth | ||||||
| Sales growth | +16.4% | +15.7% | +3.1% | -20.4% | +85.3% | - |
| EBITDA growth | +95.0% | +578.6% | -66.4% | -82.3% | +131.8% | - |
| PBT growth | -16.9% | +9998.0% | -371.1% | - | +479.3% | +9997.0% |
| Net income growth | +157.0% | +41.7% | -32.1% | -195.8% | +1283.3% | - |
| Revenue CAGR (3Y) | +11.6% | -1.7% | +15.0% | - | - | - |
| EBITDA CAGR (3Y) | +64.5% | -26.1% | -48.3% | - | - | - |
| Profitability & leverage | ||||||
| Net income margin | +5.6% | +9.0% | -4.6% | -2.2% | +9.2% | +2.0% |
| Return on capital employed | +14.9% | +6.4% | -2.2% | +1.6% | +22.1% | +6.0% |
| Return on net worth | +11.0% | -0.4% | -7.3% | -3.4% | +20.6% | +2.5% |
| Debt / equity | 0.12 | 0.22 | 0.29 | 0.31 | 0.38 | 0.38 |
| Long-term debt / equity | 0.04 | 0.11 | 0.13 | 0.08 | 0.11 | 0.14 |
| Interest cover | 8.26 | 45.91 | -59.06 | -241.76 | 11.76 | 50.14 |
| Efficiency & per share | ||||||
| Fixed asset turnover | 1.17 | 0.95 | 0.79 | 0.84 | 1.33 | 0.84 |
| Inventory turnover | 3.56 | 3.56 | 3.21 | 3.67 | 4.96 | 2.50 |
| Debtors turnover | 5.87 | 5.04 | 5.25 | 6.06 | 8.44 | 4.13 |
| EPS (₹) | 3.98 | 12.70 | (10.62) | (8.05) | 10.12 | (0.67) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 123.59 | 119.49 | 106.85 | 117.28 | 121.17 | 110.08 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 10.19 | 11.27 | 12.70 | 12.64 | 13.73 | 9.70 | 9.45 | 11.50 |
| Revenue growth (YoY) | -25.8% | +16.2% | +34.4% | +9.9% | +11.7% | - | - | - |
| Other income | 0.07 | 0.02 | 0.00 | 0.53 | 0.04 | 0.03 | 0.57 | 10.19 |
| Total expenses | 10.69 | 11.65 | 11.99 | 12.72 | 13.26 | 10.91 | 10.01 | 11.67 |
| EBITDA | (0.50) | (0.38) | 0.71 | (0.08) | 0.47 | (1.21) | (0.56) | (0.17) |
| EBITDA margin | -4.9% | -3.4% | +5.6% | -0.6% | +3.4% | -12.5% | -5.9% | -1.5% |
| Depreciation | 0.69 | 0.69 | 0.71 | 0.71 | 0.70 | 0.69 | 0.73 | 0.71 |
| Interest | 0.14 | 0.12 | 0.15 | 0.15 | 0.10 | 0.09 | 0.13 | 0.33 |
| Profit before tax | (1.26) | (1.17) | (0.15) | (0.41) | (0.29) | (1.96) | (0.85) | 8.98 |
| Tax | (0.18) | (0.20) | 0.03 | (0.10) | (0.03) | (0.57) | (0.08) | 0.95 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 50.35 | 42.94 | 49.09 | 42.55 | 52.38 | 44.41 | 51.31 |
| Revenue growth | +17.3% | -12.5% | +15.4% | -18.8% | +18.0% | -13.5% | - |
| Other income | 0.59 | 10.92 | 1.15 | 1.14 | 0.85 | 0.41 | 0.23 |
| Total expenses | 49.62 | 45.15 | 52.85 | 46.67 | 49.31 | 41.10 | 48.58 |
| Employee cost | 9.69 | 9.05 | 9.17 | 7.45 | 8.16 | 7.63 | 7.84 |
| EBITDA | 0.73 | (2.21) | (3.76) | (4.12) | 3.07 | 3.31 | 2.73 |
| EBITDA margin | +1.5% | -5.2% | -7.7% | -9.7% | +5.9% | +7.5% | +5.3% |
| Depreciation | 2.80 | 2.85 | 2.71 | 2.40 | 1.91 | 4.20 | 1.99 |
| Interest | 0.53 | 0.94 | 1.63 | 1.38 | 1.68 | 1.60 | 0.70 |
| Profit before tax | (2.01) | 4.92 | (6.95) | (6.76) | 0.33 | (2.08) | 0.27 |
| Tax | (0.29) | 0.29 | 0.00 | (0.41) | 0.14 | (0.46) | 0.37 |
| Net profit | (1.73) | (5.76) | (6.97) | (6.36) | 0.23 | (1.79) | (0.10) |
| Net profit margin | -3.4% | -13.4% | -14.2% | -15.0% | +0.4% | -4.0% | -0.2% |
| EPS (₹) | (2.91) | 7.87 | (11.78) | (10.78) | 0.35 | (3.29) | (0.25) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 5.90 | 5.90 | 5.90 | 5.90 | 4.92 | 4.92 | 4.92 |
| Reserves & surplus | 48.53 | 50.18 | 45.55 | 52.38 | 45.38 | 44.70 | 39.70 |
| Shareholders' funds (net worth) | 54.43 | 56.08 | 51.45 | 58.28 | 50.30 | 49.62 | 44.62 |
| Secured loans | 2.70 | 0.30 | 7.58 | 9.24 | 8.30 | 11.20 | 10.69 |
| Unsecured loans | 1.18 | 1.46 | 7.79 | 1.96 | 11.10 | 4.79 | 2.36 |
| Total debt | 3.88 | 1.76 | 15.37 | 11.20 | 19.40 | 15.99 | 13.05 |
| Total liabilities | 58.58 | 58.00 | 67.99 | 70.69 | 69.90 | 65.83 | 57.85 |
| Assets | |||||||
| Gross block | 45.93 | 45.62 | 56.08 | 54.10 | 41.74 | 40.73 | 38.83 |
| Net block | 26.91 | 29.38 | 39.88 | 40.45 | 29.93 | 30.59 | 32.88 |
| Capital work in progress | 0.06 | 0.04 | 0.00 | 0.04 | 8.94 | 0.12 | 0.69 |
| Investments | 22.60 | 22.59 | 22.56 | 22.52 | 22.55 | 23.66 | 15.04 |
| Inventories | 10.64 | 7.81 | 10.98 | 8.20 | 12.19 | 10.89 | 10.69 |
| Sundry debtors | 5.97 | 5.67 | 6.57 | 7.53 | 5.35 | 7.19 | 7.55 |
| Cash & bank balances | 0.03 | 0.04 | 0.07 | 0.08 | 0.14 | 0.34 | 0.96 |
| Loans & advances | 3.40 | 2.54 | 3.23 | 3.36 | 3.67 | 4.78 | 4.56 |
| Total current assets | 20.04 | 16.06 | 20.85 | 19.17 | 21.35 | 23.20 | 23.76 |
| Total current liabilities | 14.75 | 12.90 | 17.96 | 13.91 | 14.95 | 12.81 | 14.34 |
| Net working capital | 5.29 | 3.16 | 2.89 | 5.26 | 6.40 | 10.39 | 9.42 |
| Total assets | 58.58 | 58.00 | 67.99 | 70.69 | 69.90 | 65.83 | 57.85 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.02 | 0.03 | 0.01 | 0.05 | 0.26 | 0.87 | 2.16 |
| Net cash from operating activities | (2.02) | (1.59) | (3.06) | (1.42) | 6.80 | 0.67 | 4.23 |
| Net cash from investing activities | 0.28 | 16.14 | (2.04) | (3.55) | (8.78) | (2.65) | (8.43) |
| Net cash from financing activities | 1.75 | (14.56) | 5.12 | 4.94 | 1.77 | 1.37 | 2.91 |
| Net change in cash | 0.00 | (0.01) | 0.02 | (0.04) | (0.21) | (0.61) | (1.29) |
| Closing cash | 0.03 | 0.04 | 0.07 | 0.08 | 0.14 | 0.34 | 0.96 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +17.3% | -12.5% | +15.4% | -18.8% | +18.0% | -13.5% | - |
| EBITDA growth | +133.0% | +41.2% | +8.7% | -234.2% | -7.3% | +21.3% | - |
| PBT growth | - | +9998.0% | -2.8% | - | +9998.0% | - | -91.1% |
| Net income growth | +70.0% | +17.4% | -9.6% | -2865.2% | +112.9% | -1690.0% | - |
| Revenue CAGR (3Y) | +5.8% | -6.4% | +3.4% | -6.1% | +4.0% | -7.4% | -4.1% |
| EBITDA CAGR (3Y) | - | - | - | - | +11.4% | -9.1% | -19.4% |
| Profitability & leverage | |||||||
| Net income margin | -3.4% | +10.8% | -14.2% | -14.9% | +0.4% | -3.7% | -0.2% |
| Return on capital employed | -2.5% | -6.7% | -7.7% | -7.7% | +3.0% | -0.8% | +1.8% |
| Return on net worth | -3.1% | -10.7% | -12.7% | -11.7% | +0.4% | -3.4% | -0.3% |
| Debt / equity | 0.05 | 0.16 | 0.24 | 0.28 | 0.35 | 0.31 | 0.23 |
| Long-term debt / equity | 0.02 | 0.08 | 0.11 | 0.08 | 0.12 | 0.17 | 0.16 |
| Interest cover | -25.60 | -18.58 | -25.19 | -21.17 | 144.83 | -179.78 | 94.59 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.10 | 0.84 | 0.89 | 0.89 | 1.27 | 1.12 | 1.69 |
| Inventory turnover | 5.46 | 4.57 | 5.12 | 4.17 | 4.54 | 4.12 | 4.60 |
| Debtors turnover | 8.65 | 7.02 | 6.96 | 6.61 | 8.35 | 6.03 | 8.18 |
| EPS (₹) | (2.91) | 7.87 | (11.78) | (10.78) | 0.35 | (3.29) | (0.25) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 92.25 | 95.04 | 87.19 | 98.78 | 102.30 | 100.92 | 90.74 |
Shareholding Pattern of Makers Laboratories Ltd
Shareholding for the quarter ended Sep 2026: promoters hold 61.30%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.40% and retail and other public shareholders hold 38.30%.
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 61.30% | 61.30% | 61.30% | 61.30% |
| Public | 38.70% | 38.70% | 38.70% | 38.70% |
Group Structure of Makers Laboratories Ltd
Makers Laboratories has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Resonance Specialties Limited | L25209MH1989PLC051993 | - |
Showing major subsidiaries. Total: 1.
Charges & Borrowings of Makers Laboratories Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Nov 2020 | Yes Bank Limited | ₹8 Cr | Open |
| 19 Oct 2000 | The Saraswat Co-Op Bank Ltd. | ₹3.9 Lakh | Open |
| 19 Nov 1999 | Sarawat Co-Operative Bank Ltd. | ₹12.88 Lakh | Open |
| 11 Mar 1998 | The Shamrao Vithal Co-Op. Bank Ltd. | ₹97 Lakh | Open |
| 24 May 1996 | State Bank of India | ₹2.93 Cr | Open |
Total charge records: 20 View all charges
Employees and EPFO Compliance at Makers Laboratories Ltd
Makers Laboratories Ltd has a workforce of 139 employees as of Feb 27, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Makers Laboratories Ltd
Makers Laboratories has 14 GST registrations: 4 active and 10 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACM8382J2Z1 | Maharashtra | Active | 11 Jul 2017 |
| 03AAACM8382J1ZC | Punjab | Active | 01 Jul 2017 |
| 24AAACM8382J1Z8 | Gujarat | Active | 01 Jul 2017 |
| 06AAACM8382J1Z6 | Haryana | Active | 01 Oct 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Legal Cases of Makers Laboratories Ltd
Makers Laboratories Ltd has 51 court cases on record: 41 filed by Makers Laboratories, 5 filed against it, 5 where it is another party. 18 cases are pending and 33 are disposed. Status as checked between 23 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 39 | 1 | 17 |
| High courts | 12 | 4 | 1 |
Cases on record (5 of 51)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Appeal | Filed by the company against Ankur Drugs and Pharma Limited | Disposed |
| High Court of Delhi | Court case (CS(OS)) | Filed against the company by Win-Medicare Private Limited | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SS CASES S) | Filed by the company against Sanjana Healthcare Private Limited | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed by the company against Adley Lab Limited | Disposed |
| Bombay High Court | Court case (S) | Filed by the company against Adley Lab Limited | Disposed |
Full case history
All 51 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit Ratings, Litigation & Regulatory Alerts for Makers Laboratories Ltd
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Makers Laboratories Ltd
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Makers Laboratories Ltd
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Makers Laboratories Ltd
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Makers Laboratories Ltd
Recent News on Makers Laboratories Ltd
Frequently Asked Questions about Makers Laboratories Ltd
Makers Laboratories is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 July 1984 (42+ years old) and is registered under CIN L24230MH1984PLC033389. Listed on BSE: 506919.
Makers Laboratories reported revenue of ₹140.59 Cr for FY 2025-26 (up 16.4% YoY) based on consolidated financials.
Makers Laboratories has 6 current directors:
- Saahil Umesh Parikh - Whole-Time Director
- Nilesh Jain - Whole-Time Director
- Raj Kamal Prasad Verma - Director
- Prashant Godha - Director
- Vishal Babulal Jain - Director
- Dipti Chinubhai Shah - Director
The GSTIN of Makers Laboratories is 27AAACM8382J2Z1, registered in Maharashtra. The company has 14 GST registrations in all, of which 4 are active and 10 are cancelled or inactive. Other active GSTINs include 03AAACM8382J1ZC (Punjab), 24AAACM8382J1Z8 (Gujarat), 06AAACM8382J1Z6 (Haryana).
The CIN (Corporate Identification Number) of Makers Laboratories is L24230MH1984PLC033389. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Makers Laboratories is listed on BSE with code 506919.
Makers Laboratories has 51 court cases on record: 41 filed by the company and 5 filed against it. 18 are pending. Most are in the district courts.
Makers Laboratories was incorporated on 09 July 1984, making it 42+ years old. It is registered with the Registrar of Companies, Mumbai.
Makers Laboratories can be reached through the website makerslabs.com. Its registered office is in Mumbai, Maharashtra, India.